Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases
Insights
This report details three infant cases of fatty acid oxidation disorders, including carnitine/acylcarnitine translocase deficiency, medium chain acyl CoA dehydrogenase deficiency, and systemic primary carnitine deficiency. Early diagnosis and intervention are crucial for managing these severe metabolic conditions.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Mitochondrial fatty acid oxidation disorders (FAODs) are a group of inherited metabolic diseases.
- These disorders impair the body's ability to break down fatty acids for energy, leading to severe health problems, especially in infants.
Observation:
- Case 1: A male infant with carnitine/acylcarnitine translocase deficiency (CACT) presented with cardiac arrest, hypoglycemia, and metabolic acidosis, showing elevated palmitoylcarnitine.
- Case 2: A male infant with medium chain acyl CoA dehydrogenase (MCAD) deficiency experienced cardiac arrest after a viral illness, with characteristic urine organic acid findings.
- Case 3: A female infant with systemic primary carnitine deficiency (CDSP) exhibited dilated cardiomyopathy, hepatomegaly, and hypotonia, with extremely low carnitine levels.
Findings:
- Tandem mass spectrometry and gas liquid chromatography-mass spectrometry are key diagnostic tools for identifying specific FAODs.
- Elevated acylcarnitine levels (e.g., palmitoylcarnitine) and abnormal urine organic acids are indicative of specific deficiencies.
- Systemic primary carnitine deficiency can present with cardiomyopathy and hypotonia without hypoglycemia.
Implications:
- Early detection of FAODs through newborn screening and biochemical testing is vital for timely management.
- Understanding the specific biochemical profiles associated with each FAOD aids in accurate diagnosis and prognosis.
- Genetic counseling and family screening are important due to the inherited nature of these disorders.
Abstract:
Three infants with documented mitochondrial fatty acid oxidation disorders are described in this report. Case 1. Carnitine/acylcarnitine translocase deficiency. (CACT) (OMIM 212138) A two-day-old male developed sudden cardiac arrest 48 hours postpartum, with a previous history of early death (day 2) in siblings with a history of parental consanguinity; somnolence, inactivity, refusal to suck within 24 h, hepatomegaly, persistent hypoglycemia, hypocalcemia, hyperkalemia and severe metabolic acidosis prior to cardiac arrest. Dried blood spots by tandem mass spectrometry demonstrated 10 x elevation of palmitoylcarnitine, moderate elevation of oleylcarnitine, steroylcarnitine and myristoylcarnitine. Case 2. Medium chain acyl CoA dehydrogenase (MCAD) deficiency. (OMIM 212139) A six-week-old male infant, developed sudden cardiac arrest after contacting a viral illness, resuscitated successfully in the first episode, only to succumb during the second episode, 2 weeks apart. Plasma acylcarnitine via tandem mass spectrometry was reported normal; however, urine organic acids via gas liquid chromatography and mass spectrometry demonstrated characteristic metabolites consistent with MCADD. Case 3. Carnitine deficiency, systemic primary. (CDSP) (OMIM 212140) A one-year-old girl with progressive dyspnea since birth and a history of parental consanguinity. Severe dilated cardiomyopathy with episodes of cardiac decompensations, hepatomegaly, anemia, generalized hypotonia, but no hypoglycemia were demonstrated prior to cardiac arrest. Extremely low carnitine level noted in dried blood spots via tandem mass spectrometry.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Animal Mitochondrial Genetics
